US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition
Release time：2024-05-22 00:11:25 Source：Worldly Watch news portal
WASHINGTON (AP) — Federal regulators are challenging patents on 20 brand name drugs, including the blockbuster weight-loss injection Ozempic, in the latest action by the Biden administration targeting industry practices that drive up pharmaceutical prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
- Previous：IF starring Ryan Reynolds lands at the top of a lackluster box office with less
- Next：Shooting injures 2 at Missouri high school graduation ceremony
Related articles
- Analysis: Larson enters conversation with Verstappen as best drivers in the world
- EPA rule bans toxic chemical methylene chloride, toxic solvent known to cause liver cancer
- Ahead of the Paris Olympics, police clear a migrant camp near City Hall
- Haiti prime minister: transitional council names new leader
- Elon Musk gets approval from FDA to implant his Neuralink brain chip into a second patient
- Women can stand the cold BETTER than men, surprising study finds
- Immigrant's $1.3B Powerball win spotlights the Iu Mien community
- Lilly rides Mounjaro, Zepbound to better
- France is trying Syrian ex
- US, Mexico drop bid to host 2027 World Cup
- Padres second baseman Xander Bogaerts leaves game against Braves with shoulder injury
- Iran commutes a tycoon's death sentence to 20 years in prison
- Finnish hacker imprisoned for accessing thousands of psychotherapy records and demanding ransoms
- US, Mexico drop bid to host 2027 World Cup
- Kevin Pillar gets 1,000th career hit in Angels' win at Texas
- California's population grew in 2023, halting 3 years of decline
- Using a walker boot for too long may mean you can't ever walk properly without it again
- Women can stand the cold BETTER than men, surprising study finds
- Harris accepts debate invite to face off with Trump's VP pick, which may come at convention
- US, Mexico drop bid to host 2027 World Cup
Random recommendation
- Copyright © 2024 Powered by US challenges 'bogus' patents on Ozempic and other drugs in effort to spur competition ,Worldly Watch news portal sitemap